Prof. Dr. Avinash Tekade: Professor of Pharmaceutics & Dean, Research & Development at Marathwada Mitra Mandal’s College of Pharmacy, Thergaon, Pune
Dr. Avinash R. Tekade is a distinguished pharmaceutical scientist and educator with more than 27 years of rich experience in teaching, research, and academic leadership. He currently holds the positions of Professor and Head of the Department of Pharmaceutics as well as Dean of Research and Development at Marathwada Mitra Mandal’s College of Pharmacy in Pune. Dr. Tekade’s expertise lies in pharmaceutical nanotechnology, novel drug delivery systems, and translational research aimed at improving therapeutic efficacy and patient compliance. His dedication to research and education has established him as a respected figure in the pharmaceutical sciences community.
Online Profiles
Dr. Avinash R. Tekade is a renowned pharmaceutical scientist based at Marathwada Mitra Mandal’s College of Pharmacy, Pune, India. With a Scopus Author ID of 21834750200 and an ORCID identifier 0000-0001-8564-1859, he has made significant contributions to the field of pharmaceutics, reflected by over 1,683 citations across 44 published documents. His impactful research has been cited by more than 1,479 scholarly works, establishing his academic footprint with an h-index of 21. Dr. Tekade’s work primarily focuses on novel drug delivery systems and pharmaceutical nanotechnology, making him a leading figure in advancing therapeutic sciences.
Education
Dr. Tekade completed his Bachelor of Pharmacy (B.Pharm) with first-class honors from RTM Nagpur University in 1995, followed by a Master of Pharmacy (M.Pharm) specializing in Pharmaceutics from BITS Pilani in 1999. He further enhanced his research skills by obtaining a Ph.D. in Pharmaceutical Sciences from KBC North Maharashtra University in 2010. Throughout his academic journey, he focused on the development of advanced drug delivery systems, which laid the foundation for his subsequent research career and innovations in pharmaceutical nanotechnology.
Research Focus
His primary research interests include the design and development of novel drug delivery systems such as lipid nanoparticles, solid dispersions, and targeted nanocarriers. Dr. Tekade is especially focused on overcoming challenges related to poor drug solubility and bioavailability. Recently, his work has expanded to exploring nasal-to-brain delivery routes, aiming to improve treatments for central nervous system disorders by bypassing the blood-brain barrier. He also investigates transdermal drug delivery systems, contributing to safer and more effective patient-centric therapeutic options.
Experience
Dr. Tekade has held academic positions ranging from lecturer to professor and head of department, spanning nearly three decades. He has taught undergraduate, postgraduate, and doctoral students, fostering the next generation of pharmaceutical scientists. He has supervised over 85 M.Pharm theses and 7 Ph.D. candidates, many of whom have gone on to contribute to academia and industry. Beyond teaching, he has managed multiple funded research projects from national agencies like the Department of Science & Technology (DST) and the Rajiv Gandhi Science & Technology Commission (RGSTC), cumulatively worth over Rs. 90 lakhs.
Research Timeline & Activities
Dr. Tekade began publishing research articles in 2005 and has since authored more than 60 peer-reviewed journal papers, book chapters, and conference proceedings. His pioneering studies on nanoparticulate drug delivery, dry powder inhalations, and solid dispersions have been well recognized in the scientific community. He has filed multiple patents related to pharmaceutical formulations and delivery technologies. Active participation in international conferences and workshops reflects his commitment to continuous learning and sharing knowledge globally.
Awards & Honors
Dr. Tekade’s contributions have been acknowledged through several prestigious awards. Among them, the Prof. Man Mohan Sharma Science & Technology Award presented by the Marathi Vidnyan Parishad, Mumbai, in 2019 stands out for recognizing his innovative work in pharmaceutical sciences. He has received grants and fellowships from leading science bodies and has been invited as a keynote speaker at various international symposia, showcasing his role as a thought leader in drug delivery research.
Top Noted Publication
One of Dr. Tekade’s most influential works is his chapter titled “Nanoparticles for direct nose-to-brain drug delivery: Implications of targeting approaches,” published in the book Direct Nose-to-Brain Drug Delivery by Academic Press in 2021. This publication is highly cited for advancing the understanding of how nanoparticulate carriers can bypass the blood-brain barrier to deliver drugs effectively for neurological conditions, thus opening new avenues in CNS therapeutics and nanomedicine.
Design and assessment of in-situ nasal gel incorporated with nanostructured cubosomes for the targeted therapy of schizophrenia
Journal of Research in Pharmacy, 2025 (Open Access)
This innovative study explores the development of a nasal gel formulation using nanostructured cubosomes aimed at enhancing targeted drug delivery for schizophrenia, highlighting novel approaches in neurotherapeutics.RP-HPLC Method Development and Validation for the Determination of Remdesivir in IV Formulation
Indian Drugs, 2025
This article presents a validated reverse-phase high-performance liquid chromatography (RP-HPLC) method for accurately quantifying remdesivir in intravenous formulations, contributing essential analytical tools for pharmaceutical quality control.Development and Evaluation of Remdesivir Dry Powder Inhalation Formulation by Spray Drying Technique
Journal of Applied Pharmaceutical Science, 2025 (Open Access)
This research focuses on the formulation of remdesivir as a dry powder for inhalation via spray drying, offering promising alternatives for pulmonary delivery of antiviral drugs.Core-Shell Nanoparticles for Pulmonary Drug Delivery
A comprehensive review discussing the design, advantages, and therapeutic applications of core-shell nanoparticles, emphasizing their potential for targeted and controlled pulmonary drug delivery.
Strengths for Pharmaceutical Innovation Award
Pioneering Research in Nanotechnology-Based Drug Delivery:
Dr. Tekade has extensively contributed to the development of innovative drug delivery systems, including nanoparticles, nanostructured cubosomes, and dry powder inhalations. His work on nasal-to-brain delivery and pulmonary drug formulations represents a cutting-edge approach to overcoming conventional therapeutic limitations, such as poor bioavailability and blood-brain barrier penetration.Significant Academic and Research Leadership:
With over 27 years of academic experience, Dr. Tekade has demonstrated strong leadership as Professor, Head of Pharmaceutics, and Dean of Research & Development. His role in mentoring over 85 M.Pharm and 7 Ph.D. candidates highlights his dedication to nurturing future innovators in pharmaceutical sciences.High Impact Research and Recognition:
Boasting an h-index of 21 and more than 1,683 citations, Dr. Tekade’s publications are widely acknowledged and influential in the field. His chapter on nose-to-brain drug delivery is recognized as a seminal work, shaping current understanding and future research directions in CNS drug targeting.Successful Management of Funded Research Projects:
Dr. Tekade has secured and managed multiple competitive research grants totaling over Rs. 90 lakhs from reputed agencies such as DST and RGSTC. These projects underscore his capability to translate innovative ideas into funded, impactful research initiatives.Award-Winning Contributions and Global Engagement:
Recipient of the prestigious Prof. Man Mohan Sharma Science & Technology Award, Dr. Tekade is recognized for his innovation and scientific excellence. His active participation as a keynote speaker in international forums reflects his status as a global thought leader driving pharmaceutical innovation.